Allyson Mcyntre
Allyson Mcyntre is listed at AstraZeneca. Allyson is scheduled to speak at Automated Intelligent Chemistry 2026 on 24 November 2026.
Compiled from published conference agendas; not yet confirmed by Allyson. Is this you? Claim this profile.
Upcoming
Automated Intelligent Chemistry 2026 24 November 2026
Others from AstraZeneca
- Paul Hudson President, AstraZeneca US and Executive Vice President, North America 5 sessions
- Shaun Grady Chair of AstraZeneca UK 4 sessions
- Olga Obrezanova Principal Scientist, Augmented Biologics Design 3 sessions
- Christof Jaeger Senior Director - Data Science & Modelling - Substance, Pharmaceutical Sciences 2 sessions
- Goran Dahl Associate Principal Scientist 2 sessions
- Jarrod Walsh Director of Biochemical & Biophysical Screening 2 sessions
- Melanie Leveridge Vice President Assays, Profiling & Cell Sciences 2 sessions
- Miranda Cooper Statistical Science Director 2 sessions
- Roger Kirby Senior Enterprise Architect 2 sessions
- Semra Kitchen Senior Director, Search & Evaluation, R&I 2 sessions
- Stefan Geschwindner Director Biophysics 2 sessions
- Amberley Stephens Associate Principal Scientist 1 session